Summaries

Data Privacy and User Trust in Health-tech | Audrey Tsang (Clue) & Edel Coen (Molten Ventures)

Published
December 8, 2023
Read time
3
Min Read
Updated
December 18, 2023
Jenna Pitkälä
Data Privacy and User Trust in Health-tech | Audrey Tsang (Clue) & Edel Coen (Molten Ventures)
Table of contents
Share article:

Want to learn the best business insights from remarkable speakers at Slush 2023, but don’t have the time to watch the full speeches on YouTube?

You’ve come to the right place. Below is a summary of a speech by CEO of Clue, the leading period-tracking and reproductive health app, Audrey Tsang.

(psst: the notes were automatically generated with Wudpecker's AI notetaking tool. If you'd like to check these notes + transcript + audio recording without needing to log in, press here.)

<p class="h1-rich">🤏 TL;DR</p>

Clue is a menstrual and reproductive health platform that aims to help women understand their bodies and take control of their health. The CEO, Audrey, discussed the problems and challenges in reproductive health, the importance of trust in healthcare, Clue's data privacy and business model, and their research efforts. Action items include launching research studies in 2024, building and protecting user trust, expanding the health record feature, and collaborating with researchers from institutions like MIT and Berkeley.

<p class="h1-rich">✨ Summary</p>

Introduction and Background of Clue

  • Edell Cohen introduces herself as a principal of Molton Ventures, a venture capital investor.
  • Audrey, the CEO of Clue, shares her background and how she joined the company.
  • Clue is a menstrual and reproductive health platform that helps women understand their bodies and take control of their health.

The Broken State of Reproductive Health

  • Audrey discusses the problems and challenges in reproductive health, including taboos, stigma, and underdiagnosis.
  • She highlights the gender health gap and the lack of support and investment in women's health.
  • Women often face delayed diagnosis, under-treatment, and marginalization of their health concerns.

The Importance of Trust in Healthcare

  • Audrey emphasizes the importance of trust in the healthcare system and the need for doctors to take women's health concerns seriously.
  • She shares statistics about the longer wait times for diagnosis and treatment for women compared to men.
  • Trust is crucial for women to seek the care and support they need and to share their data for research purposes.

Clue's Data Privacy and Business Model

  • Audrey discusses Clue's commitment to data privacy and protection under German and EU data privacy laws.
  • Clue's business model is based on a premium subscription, ensuring that user data is not sold to third parties.
  • Transparency and clear communication about data usage and business practices are important for building trust with users.

Clue's Data Set and Research Efforts

  • Clue has an extensive data set of cycle-related health data from millions of users.
  • The data set is being used for research studies to improve the diagnosis and treatment of conditions like endometriosis, PCOS, ADHD, and depression.
  • Users have shown a high level of trust and willingness to contribute their anonymized data for research purposes.

The Future of Data-Driven Health

  • Audrey is hopeful that data-driven health solutions will become more inclusive and accessible.
  • She envisions advancements in sensors, increased engagement in personal healthcare, and improved support for reproductive health journeys.
  • By leveraging data and building trust, the aim is to decrease diagnosis time, improve treatment, and eliminate unnecessary suffering in reproductive health.
Automatic quality online meeting notes
Try Wudpecker for free
Dashboard
Data Privacy and User Trust in Health-tech | Audrey Tsang (Clue) & Edel Coen (Molten Ventures)
Min Read
Data Privacy and User Trust in Health-tech | Audrey Tsang (Clue) & Edel Coen (Molten Ventures)
Min Read
Data Privacy and User Trust in Health-tech | Audrey Tsang (Clue) & Edel Coen (Molten Ventures)
Min Read
arrow
arrow

Read more